The role of 20-HETE in androgen-mediated hypertension.

作者: Cheng-Chia Wu , Michal Laniado Schwartzman

DOI: 10.1016/J.PROSTAGLANDINS.2011.06.006

关键词:

摘要: Androgen plays an important role in blood pressure regulation. Epidemiological studies have shown that men a higher prevalence for developing hypertension than aged-matched, premenopausal women. Interestingly, postmenopausal women and with polycystic ovary syndrome, both of which increased endogenous androgen production, elevated risks suggesting may contribute to its development. Studies from our laboratory others provided substantial evidence 20-hydroxyeicosatetraenoic acid (20-HETE) mediates the seen rodents treated androgen. 20-HETE is cytochrome P450 (CYP)-derived ω-hydroxylated metabolite arachidonic acid. complex In kidney tubules, decreases by promoting natriuresis, while microvasculature it has pressor effect. microcirculation, participates regulation vascular tone sensitizing smooth muscle cells constrictor stimuli contributes myogenic, mitogenic angiogenic responses. addition, acts on endothelium promote endothelial dysfunction activation. Recently, we demonstrated induces ACE thus setting forth potential feed forward mechanism through activation Renin-Angiotensin-Aldosterone-System. this review, will discuss pro-hypertensive effects androgen-induced hypertension.

参考文章(125)
K Norris, K Nelson, D Martins, D Pan, N Tareen, The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. The journal of gender-specific medicine. ,vol. 4, pp. 10- 20 ,(2001)
Jorge H. Capdevila, J. R. Falck, Ronald W. Estabrook, Cytochrome P450 and the arachidonate cascade. The FASEB Journal. ,vol. 6, pp. 731- 736 ,(1992) , 10.1096/FASEBJ.6.2.1537463
Natalie C Ward, Kai Chen, Chunying Li, Kevin D Croft, John F Keaney, Chronic activation of AMP‐activated protein kinase prevents 20‐hydroxyeicosatetraenoic acid‐induced endothelial dysfunction Clinical and Experimental Pharmacology and Physiology. ,vol. 38, pp. 328- 333 ,(2011) , 10.1111/J.1440-1681.2011.05509.X
Jefferson C. Frisbee, John R. Falck, Julian H. Lombard, Contribution of cytochrome P-450 ω-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension American Journal of Physiology-heart and Circulatory Physiology. ,vol. 278, ,(2000) , 10.1152/AJPHEART.2000.278.5.H1517
Juergen Theuer, Ralf Dechend, Dominik N Muller, Joon-Keun Park, Anette Fiebeler, Peter Barta, Detlev Ganten, Hermann Haller, Rainer Dietz, Friedrich C Luft, Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats BMC Cardiovascular Disorders. ,vol. 2, pp. 3- 3 ,(2002) , 10.1186/1471-2261-2-3
Richard J. Roman, P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiological Reviews. ,vol. 82, pp. 131- 185 ,(2002) , 10.1152/PHYSREV.00021.2001
Auinash Kalsotra, Henry W. Strobel, Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacology & Therapeutics. ,vol. 112, pp. 589- 611 ,(2006) , 10.1016/J.PHARMTHERA.2006.03.008
Thu H Le, Thomas M Coffman, Targeting genes in the renin-angiotensin system Current Opinion in Nephrology and Hypertension. ,vol. 17, pp. 57- 63 ,(2008) , 10.1097/MNH.0B013E3282F2FD39
Carmine Savoia, Ernesto L. Schiffrin, Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions Clinical Science. ,vol. 112, pp. 375- 384 ,(2007) , 10.1042/CS20060247
Fengyun Xu, John R. Falck, Paul R. Ortiz de Montellano, Deanna L. Kroetz, Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. Journal of Pharmacology and Experimental Therapeutics. ,vol. 308, pp. 887- 895 ,(2004) , 10.1124/JPET.103.059626